Pacific Biosciences Of California Net Income 2009-2019 | PACB
Pacific Biosciences Of California net income from 2009 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Pacific Biosciences Of California Annual Net Income (Millions of US $) |
|
|---|---|
| 2018 | $-103 |
| 2017 | $-92 |
| 2016 | $-74 |
| 2015 | $-32 |
| 2014 | $-66 |
| 2013 | $-79 |
| 2012 | $-94 |
| 2011 | $-109 |
| 2010 | $-140 |
| 2009 | $-88 |
| 2008 | $-44 |
| 2007 | $-22 |
| Pacific Biosciences Of California Quarterly Net Income (Millions of US $) |
|
|---|---|
| Q3 2019 | $-29 |
| Q2 2019 | $-25 |
| Q1 2019 | $-30 |
| Q4 2018 | $-31 |
| Q3 2018 | $-25 |
| Q2 2018 | $-23 |
| Q1 2018 | $-24 |
| Q4 2017 | $-21 |
| Q3 2017 | $-22 |
| Q2 2017 | $-26 |
| Q1 2017 | $-24 |
| Q4 2016 | $-19 |
| Q3 2016 | $-17 |
| Q2 2016 | $-18 |
| Q1 2016 | $-19 |
| Q4 2015 | $-1 |
| Q3 2015 | $2 |
| Q2 2015 | $-12 |
| Q1 2015 | $-20 |
| Q4 2014 | $-19 |
| Q3 2014 | $-9 |
| Q2 2014 | $-19 |
| Q1 2014 | $-19 |
| Q4 2013 | $-17 |
| Q3 2013 | $-20 |
| Q2 2013 | $-20 |
| Q1 2013 | $-21 |
| Q4 2012 | $-22 |
| Q3 2012 | $-23 |
| Q2 2012 | $-22 |
| Q1 2012 | $-28 |
| Q4 2011 | $-23 |
| Q3 2011 | $-29 |
| Q2 2011 | $-22 |
| Q1 2011 | $-35 |
| Q4 2010 | $-36 |
| Q3 2010 | $-41 |
| Q2 2010 | $-33 |
| Q1 2010 | $-30 |
| Q4 2009 | |
| Q3 2009 | $-25 |
| Q4 2008 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.783B | $0.079B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $125.466B | 25.99 |
| Intuitive Surgical (ISRG) | United States | $66.944B | 52.61 |
| Edwards Lifesciences (EW) | United States | $51.008B | 46.32 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.998B | 14.89 |
| IDEXX Laboratories (IDXX) | United States | $21.331B | 51.59 |
| DexCom (DXCM) | United States | $20.929B | 187.43 |
| Olympus (OCPNY) | Japan | $20.322B | 152.62 |
| Teleflex (TFX) | United States | $16.317B | 33.13 |
| Sysmex ADR (SSMXY) | Japan | $14.806B | 39.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.376B | 0.00 |
| Hologic (HOLX) | United States | $13.860B | 21.18 |
| STERIS (STE) | Ireland | $12.894B | 28.48 |
| Varian Medical Systems (VAR) | United States | $12.305B | 29.17 |
| ABIOMED (ABMD) | United States | $8.631B | 46.97 |
| Masimo (MASI) | United States | $8.300B | 49.56 |
| Penumbra (PEN) | United States | $5.971B | 194.35 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Globus Medical (GMED) | United States | $5.562B | 34.33 |
| Integra LifeSciences Holdings (IART) | United States | $5.194B | 22.32 |
| Elekta AB (EKTAY) | Sweden | $4.693B | 36.13 |
| Tandem Diabetes Care (TNDM) | United States | $4.041B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.967B | 28.56 |
| Wright Medical Group (WMGI) | Netherlands | $3.760B | 227.92 |
| Nevro (NVRO) | United States | $3.491B | 0.00 |
| Cantel Medical (CMD) | United States | $3.304B | 32.75 |
| Integer Holdings (ITGR) | United States | $2.492B | 17.06 |
| Nihon Kohden (NHNKY) | Japan | $2.389B | 24.04 |
| Glaukos (GKOS) | United States | $2.224B | 0.00 |
| Inogen (INGN) | United States | $1.615B | 50.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.592B | 31.34 |
| Veracyte (VCYT) | United States | $1.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.166B | 133.26 |
| Silk Road Medical (SILK) | United States | $1.074B | 0.00 |
| Natus Medical (NTUS) | United States | $1.072B | 25.79 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.015B | 37.62 |
| CryoLife (CRY) | United States | $0.926B | 94.92 |
| Luminex (LMNX) | United States | $0.925B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.852B | 28.29 |
| Accelerate Diagnostics (AXDX) | United States | $0.799B | 0.00 |
| AxoGen (AXGN) | United States | $0.673B | 0.00 |
| Intersect ENT (XENT) | United States | $0.665B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.579B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.573B | 20.59 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ViewRay (VRAY) | United States | $0.441B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.433B | 13.10 |
| Si-Bone (SIBN) | United States | $0.433B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.422B | 0.00 |
| Sientra (SIEN) | United States | $0.406B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.317B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 39.27 |
| Stereotaxis (STXS) | United States | $0.291B | 0.00 |
| IRadimed (IRMD) | United States | $0.258B | 36.27 |
| SeaSpine Holdings (SPNE) | United States | $0.250B | 0.00 |
| Accuray (ARAY) | United States | $0.249B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.228B | 63.60 |
| Fluidigm (FLDM) | United States | $0.166B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.156B | 41.38 |
| RTI Surgical (RTIX) | United States | $0.133B | 36.00 |
| ConforMIS (CFMS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.109B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.107B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.085B | 0.00 |
| Electromed (ELMD) | United States | $0.084B | 30.00 |
| Vermillion (VRML) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.060B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.058B | 0.00 |
| TransEnterix (TRXC) | United States | $0.048B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.047B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.042B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.038B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.023B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.021B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.016B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.016B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.07 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Avinger (AVGR) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.011B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
